# External Claims Registry

Extracted from all chapter and non-chapter pages in PatentWorld.
Generated: 2026-02-21

## Methodology
Each claim is an external factual assertion not derived from the site's own PatentsView data analysis. Claims are categorized as:
- **LAW**: Patent statutes, regulations, effective dates
- **CASE**: Court decisions, holdings, case names, dates
- **POLICY**: Patent office policies, institutional changes
- **HISTORY**: Historical events, dates, legislative histories
- **DEFINITION**: Legal or technical term definitions
- **CITATION**: Academic papers, books, reports referenced
- **INSTITUTION**: Facts about organizations, companies, agencies
- **COMPARATIVE**: Claims comparing data to external benchmarks
- **METHODOLOGY**: References to established methods from literature
- **TECHNOLOGY_CONTEXT**: Claims about technologies (e.g., expiration dates, first demos)

---

## Claims Registry

| Claim ID | File Path | Section | Quoted Text | Category | Notes |
|----------|-----------|---------|-------------|----------|-------|
| 1 | src/app/chapters/system-patent-law/page.tsx | Timeline: Bayh-Dole (line 28-31) | "Bayh-Dole Act (1980) -- Permitted universities and small businesses to patent federally funded inventions. Transformed university technology transfer and substantially increased academic patenting." | LAW | Effective date 1980; describes scope of the act |
| 2 | src/app/chapters/system-patent-law/page.tsx | Timeline: Bayh-Dole research (line 34-36) | Jensen, R., & Thursby, M. (2001). Proofs and prototypes for sale: The licensing of university inventions. American Economic Review, 91(1), 240-259. | CITATION | Academic paper on university licensing |
| 3 | src/app/chapters/system-patent-law/page.tsx | Timeline: Bayh-Dole research (line 38-39) | Thursby, J. G., & Thursby, M. C. (2002). Who is selling the ivory tower? Sources of growth in university licensing. Management Science, 48(1), 90-104. | CITATION | Academic paper on university licensing growth |
| 4 | src/app/chapters/system-patent-law/page.tsx | Timeline: Bayh-Dole research (line 42-43) | Zucker, L. G., Darby, M. R., & Brewer, M. B. (1998). Intellectual human capital and the birth of U.S. biotechnology enterprises. American Economic Review, 88(1), 290-306. | CITATION | Academic paper on biotech firm births |
| 5 | src/app/chapters/system-patent-law/page.tsx | Timeline: Bayh-Dole research (line 46-47) | Agrawal, A., & Henderson, R. M. (2002). Putting patents in context: Exploring knowledge transfer from MIT. Management Science, 48(1), 44-60. | CITATION | Academic paper on MIT knowledge transfer |
| 6 | src/app/chapters/system-patent-law/page.tsx | Timeline: Stevenson-Wydler (line 52-55) | "Stevenson-Wydler Act (1980) -- Required federal labs to actively participate in technology transfer. Created Office of Research and Technology Applications in major federal labs." | LAW | Effective date 1980; institutional mandate |
| 7 | src/app/chapters/system-patent-law/page.tsx | Timeline: Stevenson-Wydler research (line 58-59) | Cohen, W. M., Nelson, R. R., & Walsh, J. P. (2002). Links and impacts: The influence of public research on industrial R&D. Management Science, 48(1), 1-23. | CITATION | Academic paper on public research influence |
| 8 | src/app/chapters/system-patent-law/page.tsx | Timeline: Federal Circuit (line 64-67) | "Federal Circuit Created (1982) -- Established the Court of Appeals for the Federal Circuit (CAFC) as the single appellate court for patent cases, unifying patent law and generally strengthening patent rights." | LAW | Creation of CAFC in 1982 |
| 9 | src/app/chapters/system-patent-law/page.tsx | Timeline: Federal Circuit research (line 70-71) | Galasso, A., & Schankerman, M. (2015). Patents and cumulative innovation: Causal evidence from the courts. The Quarterly Journal of Economics, 130(1), 317-369. | CITATION | Academic paper on patent invalidation effects |
| 10 | src/app/chapters/system-patent-law/page.tsx | Timeline: Federal Circuit research (line 74-75) | Hou, Y., Png, I. P. L., & Xiong, X. (2023). When stronger patent law reduces patenting: Empirical evidence. Strategic Management Journal, 44(4), 977-1012. | CITATION | Academic paper; claims businesses reduced strategic patenting by 23.3% |
| 11 | src/app/chapters/system-patent-law/page.tsx | Timeline: Federal Circuit research (line 78-79) | Hall, B. H., & Ziedonis, R. H. (2001). The patent paradox revisited. RAND Journal of Economics, 32(1), 101-128. | CITATION | Academic paper on semiconductor patent paradox |
| 12 | src/app/chapters/system-patent-law/page.tsx | Timeline: Federal Circuit research (line 82-83) | Somaya, D., & McDaniel, C. A. (2012). Tribunal specialization and institutional targeting in patent enforcement. Organization Science, 23(3), 869-887. | CITATION | Academic paper on patent enforcement strategies |
| 13 | src/app/chapters/system-patent-law/page.tsx | Timeline: Hatch-Waxman (line 88-91) | "Hatch-Waxman Act (1984) -- Balanced generic drug entry with patent term restoration for pharma patents delayed by FDA review. Created the modern framework for pharmaceutical patent litigation." | LAW | Effective date 1984; describes scope |
| 14 | src/app/chapters/system-patent-law/page.tsx | Timeline: Hatch-Waxman research (line 94-95) | Budish, E., Roin, B. N., & Williams, H. L. (2015). Do firms underinvest in long-term research? American Economic Review, 105(7), 2044-2085. | CITATION | Academic paper on R&D investment distortions |
| 15 | src/app/chapters/system-patent-law/page.tsx | Timeline: Hatch-Waxman research (line 98-99) | Acemoglu, D., & Linn, J. (2004). Market size in innovation. The Quarterly Journal of Economics, 119(3), 1049-1090. | CITATION | Academic paper on pharma innovation |
| 16 | src/app/chapters/system-patent-law/page.tsx | Timeline: Hatch-Waxman research (line 102-103) | Grabowski, H. G., & Vernon, J. M. (1990). A new look at the returns and risks to pharmaceutical R&D. Management Science, 36(7), 804-821. | CITATION | Academic paper on pharma R&D returns |
| 17 | src/app/chapters/system-patent-law/page.tsx | Timeline: Hatch-Waxman research (line 106-107) | Cockburn, I. M., Lanjouw, J. O., & Schankerman, M. (2016). Patents and the global diffusion of new drugs. American Economic Review, 106(1), 136-164. | CITATION | Academic paper on drug patent diffusion |
| 18 | src/app/chapters/system-patent-law/page.tsx | Timeline: Hatch-Waxman research (line 110-111) | Scott Morton, F. M. (1999). Entry decisions in the generic pharmaceutical industry. RAND Journal of Economics, 30(3), 421-440. | CITATION | Academic paper on generic drug entry under Hatch-Waxman ANDA pathway 1984-1994 |
| 19 | src/app/chapters/system-patent-law/page.tsx | Timeline: TRIPS (line 117-119) | "TRIPS Agreement (1994) -- The Agreement on Trade-Related Aspects of Intellectual Property Rights established minimum patent protection standards globally." | LAW | TRIPS effective date 1994; global IP standards |
| 20 | src/app/chapters/system-patent-law/page.tsx | Timeline: TRIPS research (line 122-123) | Branstetter, L. G., Fisman, R., & Foley, C. F. (2006). Do stronger intellectual property rights increase international technology transfer? The Quarterly Journal of Economics, 121(1), 321-349. | CITATION | Claims royalty payments increase >30% after TRIPS reform |
| 21 | src/app/chapters/system-patent-law/page.tsx | Timeline: TRIPS research (line 130-131) | Moser, P., & Voena, A. (2012). Compulsory licensing: Evidence from the Trading with the Enemy Act. American Economic Review, 102(1), 396-427. | CITATION | Claims compulsory licensing increased domestic invention by 20%; references TRIPS Article 31 |
| 22 | src/app/chapters/system-patent-law/page.tsx | Timeline: TRIPS research (line 134-135) | Chaudhuri, S., Goldberg, P. K., & Jia, P. (2006). Estimating the effects of global patent protection in pharmaceuticals. American Economic Review, 96(5), 1477-1514. | CITATION | Academic paper on TRIPS effects in India |
| 23 | src/app/chapters/system-patent-law/page.tsx | Timeline: GATT (line 141-143) | "GATT Patent Term Change (1995) -- US patent term changed from 17 years from grant date to 20 years from earliest filing date, aligning with international standards." | LAW | Patent term change in 1995; old vs new term |
| 24 | src/app/chapters/system-patent-law/page.tsx | Timeline: State Street (line 153-155) | "State Street Bank v. Signature Financial Group (149 F.3d 1368) (1998) -- The Court of Appeals for the Federal Circuit held that business methods are patentable if they produce a 'useful, concrete, and tangible result.'" | CASE | Case citation, year 1998, holding on business method patentability |
| 25 | src/app/chapters/system-patent-law/page.tsx | Timeline: State Street research (line 158-159) | Cockburn, I. M., & MacGarvie, M. J. (2011). Entry and patenting in the software industry. Management Science, 57(5), 915-933. | CITATION | Claims 10% increase in patents reduces software market entry by 3-8% |
| 26 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIPA (line 164-167) | "American Inventors Protection Act (1999) -- Required publication of patent applications 18 months after filing (with opt-out for US-only filers). Introduced inter partes reexamination." | LAW | Effective date 1999; 18-month publication mandate |
| 27 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIPA research (line 170-171) | Hegde, D., Herkenhoff, K., & Zhu, C. (2023). Patent publication and innovation. Journal of Political Economy, 131(7), 1845-1903. | CITATION | Claims firms exposed to longer grant delays increased R&D by 4% |
| 28 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIPA research (line 174-175) | Hegde, D., & Luo, H. (2018). Patent publication and the market for ideas. Management Science, 64(2), 652-672. | CITATION | Claims licensing delays reduced by ~10 months post-AIPA |
| 29 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIPA research (line 178-179) | Luck, S., Balsmeier, B., Seliger, F., & Fleming, L. (2020). Early disclosure of invention and reduced duplication. Management Science, 66(6), 2677-2685. | CITATION | Academic paper on disclosure reducing duplicative R&D |
| 30 | src/app/chapters/system-patent-law/page.tsx | Timeline: USPTO reform (line 184-187) | "USPTO 21st Century Strategic Plan (2003) -- USPTO launched comprehensive reform to address growing patent backlog and pendency concerns." | POLICY | USPTO policy initiative in 2003 |
| 31 | src/app/chapters/system-patent-law/page.tsx | Timeline: USPTO reform research (line 190-191) | Hegde, D., Ljungqvist, A., & Raj, M. (2022). Quick or broad patents? Evidence from U.S. startups. The Review of Financial Studies, 35(6), 2705-2742. | CITATION | Academic paper on grant delay effects on startups |
| 32 | src/app/chapters/system-patent-law/page.tsx | Timeline: USPTO reform research (line 194-195) | Gans, J. S., Hsu, D. H., & Stern, S. (2008). The impact of uncertain intellectual property rights on the market for ideas. Management Science, 54(5), 982-997. | CITATION | Academic paper on patent pendency friction |
| 33 | src/app/chapters/system-patent-law/page.tsx | Timeline: eBay (line 200-203) | "eBay v. MercExchange (547 U.S. 388) (2006) -- The Court held that patent holders are not automatically entitled to injunctive relief, ending the presumption of permanent injunctions in patent cases." | CASE | Supreme Court case, 2006, holding on injunctive relief |
| 34 | src/app/chapters/system-patent-law/page.tsx | Timeline: eBay research (line 206-207) | Mezzanotti, F. (2021). Roadblock to innovation: The role of patent litigation in corporate R&D. Management Science, 67(12), 7362-7390. | CITATION | Academic paper using eBay as natural experiment |
| 35 | src/app/chapters/system-patent-law/page.tsx | Timeline: eBay research (line 210-211) | Aydin Ozden, S., & Khashabi, P. (2023). Patent remedies and technology licensing. Strategic Management Journal, 44(9), 2311-2338. | CITATION | Claims eBay reduced US firms' propensity to license |
| 36 | src/app/chapters/system-patent-law/page.tsx | Timeline: eBay research (line 214-215) | Cohen, L., Gurun, U. G., & Kominers, S. D. (2019). Patent trolls: Evidence from targeted firms. Management Science, 65(12), 5461-5486. | CITATION | Academic paper on NPE litigation effects |
| 37 | src/app/chapters/system-patent-law/page.tsx | Timeline: eBay research (line 218-219) | Farrell, J., & Shapiro, C. (2008). How strong are weak patents? American Economic Review, 98(4), 1347-1369. | CITATION | Academic paper on weak patents and royalties |
| 38 | src/app/chapters/system-patent-law/page.tsx | Timeline: KSR (line 225-227) | "KSR v. Teleflex (550 U.S. 398) (2007) -- The Court held that the rigid 'teaching-suggestion-motivation' test...was not the exclusive standard for obviousness under 35 U.S.C. S 103." | CASE | Supreme Court case, 2007, holding on obviousness standard |
| 39 | src/app/chapters/system-patent-law/page.tsx | Timeline: KSR research (line 230-231) | Schankerman, M., & Schuett, F. (2022). Patent screening, innovation, and welfare. The Review of Economic Studies, 89(4), 2101-2148. | CITATION | Claims almost half of issued patents are on inventions not requiring patent incentive |
| 40 | src/app/chapters/system-patent-law/page.tsx | Timeline: Bilski (line 237-239) | "Bilski v. Kappos (561 U.S. 593) (2010) -- The Court held that the 'machine-or-transformation' test is not the sole test for patent eligibility under 35 U.S.C. S 101." | CASE | Supreme Court case, 2010, holding on patent eligibility |
| 41 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIA (line 243-246) | "America Invents Act (AIA) (2011) -- The most comprehensive patent reform since the Patent Act of 1952. Transitioned the United States from a 'first to invent' to a 'first inventor to file' system. Established inter partes review (IPR) and post-grant review (PGR)." | LAW | AIA 2011; first-to-file; IPR/PGR creation; reference to Patent Act of 1952 |
| 42 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIA research (line 249-250) | Schankerman, M., & Schuett, F. (2022) -- claims "cheaper validity challenge mechanisms like PTAB results in welfare increases of 0.8%." | CITATION | Specific quantitative claim from academic paper |
| 43 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIA research (line 253-254) | Gaessler, F., Harhoff, D., Sorg, S., & von Graevenitz, G. (2025). Patents, freedom to operate, and follow-on innovation. Management Science, 71(2), 1315-1334. | CITATION | Claims patent invalidation through opposition increases follow-on innovation by 16% |
| 44 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIA research (line 261-262) | Huang, K. G., Li, M.-X., Shen, C. H.-H., & Wang, Y. (2024). Escaping the patent trolls. Strategic Management Journal, 45(10), 1954-1987. | CITATION | Academic paper on NPE litigation effects on innovation strategy |
| 45 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIA research (line 265-266) | Helmers, C., & Love, B. J. (2023). Patent validity and litigation: Evidence from US inter partes review. Journal of Law & Economics, 66(1), 53-81. | CITATION | Academic paper analyzing AIA's IPR mechanism directly |
| 46 | src/app/chapters/system-patent-law/page.tsx | Timeline: AIA first-to-file (line 272-274) | "AIA's first-inventor-to-file provision took effect March 16, 2013" | LAW | Specific effective date for AIA provision |
| 47 | src/app/chapters/system-patent-law/page.tsx | Timeline: Myriad (line 279-281) | "Association for Molecular Pathology v. Myriad (569 U.S. 576) (2013) -- The Court held that naturally occurring DNA segments are not patent-eligible under 35 U.S.C. S 101, but that synthetically created complementary DNA (cDNA) is patent-eligible." | CASE | Supreme Court case, 2013, holding on DNA patentability |
| 48 | src/app/chapters/system-patent-law/page.tsx | Timeline: Myriad research (line 284-285) | Sampat, B. N., & Williams, H. L. (2019). How do patents affect follow-on innovation? Evidence from the human genome. American Economic Review, 109(1), 203-236. | CITATION | Academic paper on gene patent effects |
| 49 | src/app/chapters/system-patent-law/page.tsx | Timeline: Myriad research (line 288-289) | Williams, H. L. (2013). Intellectual property rights and innovation: Evidence from the human genome. Journal of Political Economy, 121(1), 1-27. | CITATION | Claims Celera's IP led to 20-30% reductions in subsequent research |
| 50 | src/app/chapters/system-patent-law/page.tsx | Timeline: Myriad research (line 292-293) | Huang, K. G., & Murray, F. E. (2009). Does patent strategy shape the long-run supply of public knowledge? Academy of Management Journal, 52(6), 1193-1221. | CITATION | Academic paper on gene patents decreasing public genetic knowledge |
| 51 | src/app/chapters/system-patent-law/page.tsx | Timeline: Alice (line 299-301) | "Alice Corp. v. CLS Bank International (573 U.S. 208) (2014) -- The Court held that claims directed to an abstract idea implemented on a generic computer are not patent-eligible under 35 U.S.C. S 101, establishing a two-step framework." | CASE | Supreme Court case, 2014, holding on software patent eligibility |
| 52 | src/app/chapters/system-patent-law/page.tsx | Timeline: TC Heartland (line 315-317) | "TC Heartland v. Kraft Foods (581 U.S. 258) (2017) -- The Court held that patent infringement suits must be filed where the defendant is incorporated, restricting venue rules." | CASE | Supreme Court case, 2017, holding on patent venue |
| 53 | src/app/chapters/system-patent-law/page.tsx | Timeline: Oil States (line 331-333) | "Oil States v. Greene's Energy (584 U.S. 325) (2018) -- The Court held that inter partes review (IPR) proceedings at the PTAB are constitutional." | CASE | Supreme Court case, 2018, holding on IPR constitutionality |
| 54 | src/app/chapters/system-patent-law/page.tsx | Timeline: SAS Institute (line 343-345) | "SAS Institute v. Iancu (584 U.S. 357) (2018) -- The Court held that the PTAB must review all claims challenged in an IPR petition, not merely a subset." | CASE | Supreme Court case, 2018, holding on PTAB scope |
| 55 | src/app/chapters/system-patent-law/page.tsx | Timeline: Exec Order (line 349-351) | "Executive Order on Competition (2021) -- directed federal agencies to address the misuse of patents and strengthened patent system transparency initiatives." | POLICY | 2021 Executive Order on competition |
| 56 | src/app/chapters/system-patent-law/page.tsx | Timeline: Exec Order research (line 354-355) | Lerner, J., & Tirole, J. (2015). Standard-essential patents. Journal of Political Economy, 123(3), 547-586. | CITATION | Academic paper on standard-essential patents and FRAND |
| 57 | src/app/chapters/system-patent-law/page.tsx | Timeline: PREVAIL/PERA (line 361-363) | "Proposed PREVAIL Act (S.1553) & Patent Eligibility Restoration Act (S.1546) were reintroduced in the 119th Congress. As of 2025, both bills remain under committee consideration and have not been enacted." | LAW | Pending legislation, bill numbers, 119th Congress, 2025 status |
| 58 | src/app/chapters/system-patent-law/page.tsx | Exec Summary (line 470) | "an era of expansion from the early 1980s through 2000...followed by an era of recalibration" | HISTORY | Characterization of two broad regulatory phases in patent law |
| 59 | src/app/chapters/system-public-investment/page.tsx | Key Findings (line 80) | "consistent with findings in the academic literature (Azoulay et al., 2019, JPE; Mowery et al., 2001, Research Policy)" | CITATION | References to specific academic publications |
| 60 | src/app/chapters/system-public-investment/page.tsx | Exec Summary (line 86) | "Azoulay, Graff Zivin, Li, & Sampat, 2019; Jaffe & Lerner, 2001; Mowery, Nelson, Sampat, & Ziedonis, 2001; Sampat, 2006" | CITATION | Four academic citations on government-funded patent quality |
| 61 | src/app/chapters/system-public-investment/page.tsx | Key Insight (line 153-156) | "Azoulay, Graff Zivin, Li, and Sampat (2019), 'Public R&D Investments and Private-sector Patenting,' Journal of Political Economy 127(4), 1640-1671; Jaffe, A.B. and Lerner, J. (2001)...RAND Journal of Economics; Mowery, D.C., Nelson, R.R., Sampat, B.N., and Ziedonis, A.A. (2001)...Research Policy 30(1), 99-119; Sampat, B.N. (2006)...Research Policy 35(6), 772-789." | CITATION | Full academic citations with journal, volume, page numbers |
| 62 | src/app/chapters/biotechnology/page.tsx | Key Findings (line 264) | "Biotechnology patenting has grown substantially since the 1980s, following the Bayh-Dole Act (1980) which enabled universities to patent federally funded inventions." | LAW | Bayh-Dole Act 1980 enabling university patenting |
| 63 | src/app/chapters/biotechnology/page.tsx | Key Findings (line 265) | "The completion of the Human Genome Project in 2003 and the publication of CRISPR-Cas9 gene editing in 2012 represent inflection points" | TECHNOLOGY_CONTEXT | Human Genome Project completion 2003; CRISPR-Cas9 publication 2012 |
| 64 | src/app/chapters/biotechnology/page.tsx | Key Findings (line 267) | "The development and patenting of mRNA vaccine technology during the COVID-19 pandemic occurred at an accelerated pace relative to typical biotech development timelines." | TECHNOLOGY_CONTEXT | mRNA vaccine acceleration during COVID-19 |
| 65 | src/app/chapters/biotechnology/page.tsx | Exec Summary (line 276-277) | "the completion of the Human Genome Project in 2003 and the discovery of CRISPR-Cas9 gene editing in 2012" | TECHNOLOGY_CONTEXT | Dates for HGP completion and CRISPR discovery |
| 66 | src/app/chapters/biotechnology/page.tsx | Exec Summary (line 282-283) | "mRNA vaccine technology moved from laboratory concept to global deployment in under a year" | TECHNOLOGY_CONTEXT | mRNA vaccine development timeline claim |
| 67 | src/app/chapters/biotechnology/page.tsx | Key Insight (line 308-310) | "The field has been shaped by a series of landmark scientific breakthroughs -- recombinant DNA technology, polymerase chain reaction, the Human Genome Project, and CRISPR-Cas9" | TECHNOLOGY_CONTEXT | Lists four landmark biotech breakthroughs |
| 68 | src/app/chapters/biotechnology/page.tsx | Key Insight (line 419-425) | "gene editing...associated with the development of CRISPR-Cas9 technology...Enzyme engineering and nucleic acid detection...reflecting advances in directed evolution (recognized by the 2018 Nobel Prize in Chemistry) and the proliferation of PCR-based and advanced sequencing diagnostic platforms, particularly during the COVID-19 pandemic." | TECHNOLOGY_CONTEXT | 2018 Nobel Prize in Chemistry for directed evolution |
| 69 | src/app/chapters/biotechnology/page.tsx | Ethical section (line 843-844) | "The Supreme Court's decision in Association for Molecular Pathology v. Myriad Genetics (2013) established that naturally occurring DNA sequences cannot be patented, while synthetic cDNA remains patentable" | CASE | Myriad decision, 2013, DNA patentability holding |
| 70 | src/app/chapters/biotechnology/page.tsx | Ethical section (line 846-847) | "The ongoing CRISPR patent dispute between the Broad Institute and the University of California" | CASE | CRISPR patent dispute between Broad Institute and UC |
| 71 | src/app/chapters/biotechnology/page.tsx | Ethical section (line 867) | "a process that typically costs over a billion dollars and spans more than a decade" | COMPARATIVE | External benchmark for drug development cost and timeline |
| 72 | src/app/chapters/biotechnology/page.tsx | InsightRecap (line 952) | "gene-editing subclass patents should show discontinuous growth after the 2012 Doudna-Charpentier publication" | TECHNOLOGY_CONTEXT | Attributes CRISPR publication to Doudna-Charpentier, 2012 |
| 73 | src/app/chapters/blockchain/page.tsx | Exec Summary (line 278) | "The Bitcoin whitepaper of 2009 planted the seed...smart contracts after Ethereum's 2015 launch, the ICO boom of 2017, and the NFT/DeFi surge of 2021" | TECHNOLOGY_CONTEXT | Bitcoin whitepaper 2009; Ethereum launch 2015; ICO boom 2017; NFT/DeFi peak 2021 |
| 74 | src/app/chapters/blockchain/page.tsx | Narrative (line 287-288) | "Blockchain technology -- originally conceived as the infrastructure underlying Bitcoin" | TECHNOLOGY_CONTEXT | Blockchain's origin as Bitcoin infrastructure |
| 75 | src/app/chapters/blockchain/page.tsx | Hype Cycle (line 822-828) | "The Bitcoin whitepaper of 2009 sparked initial interest. Ethereum's launch in 2015 expanded the conceptual scope...The ICO boom of 2017 and the NFT/DeFi peak of 2021 coincided with successive waves of patent filings." | TECHNOLOGY_CONTEXT | Timeline of blockchain/crypto milestones |
| 76 | src/app/chapters/blockchain/page.tsx | Key Insight (line 461-462) | "IBM's leadership reflects its early investment in Hyperledger and enterprise blockchain platforms." | INSTITUTION | IBM's Hyperledger investment |
| 77 | src/app/chapters/3d-printing/page.tsx | Key Findings (line 265) | "3D printing patent filings have grown substantially since 2000, with notable acceleration after the expiration of key FDM patents in 2009." | TECHNOLOGY_CONTEXT | FDM patent expiration in 2009 |
| 78 | src/app/chapters/3d-printing/page.tsx | Exec Summary (line 274) | "the foundational stereolithography patents of the 1980s...the desktop 3D printing expansion triggered by FDM patent expirations" | TECHNOLOGY_CONTEXT | Stereolithography patents originated in 1980s; FDM expirations triggered desktop expansion |
| 79 | src/app/chapters/3d-printing/page.tsx | Caption (line 309) | "The sharp acceleration after 2009 coincides with the expiration of Stratasys's foundational FDM patent" | TECHNOLOGY_CONTEXT | Stratasys as holder of foundational FDM patent; expiration 2009 |
| 80 | src/app/chapters/3d-printing/page.tsx | Key Findings (line 268) | "The introduction of the B33Y CPC classification specifically for additive manufacturing reflects the field's maturation" | METHODOLOGY | CPC classification B33Y created for AM |
| 81 | src/app/chapters/3d-printing/page.tsx | Key Insight (line 479-481) | "Through the 2000s, Stratasys and 3D Systems held largely unchallenged positions at the top, reflecting their roles as the foundational firms in FDM and stereolithography, respectively." | INSTITUTION | Stratasys = FDM pioneer; 3D Systems = stereolithography pioneer |
| 82 | src/app/chapters/space-technology/page.tsx | Exec Summary (line 273) | "The founding of SpaceX in 2002 and the subsequent demonstration of reusable rocket technology catalyzed a broader commercial space movement" | TECHNOLOGY_CONTEXT | SpaceX founding 2002; reusable rocket technology |
| 83 | src/app/chapters/space-technology/page.tsx | Key Insight (line 405) | "global connectivity initiatives such as Starlink and Project Kuiper" | INSTITUTION | Names Starlink and Project Kuiper as satellite constellation programs |
| 84 | src/app/chapters/space-technology/page.tsx | Key Insight (line 538) | "France, Japan, and Germany maintain significant positions, supported by their national space agencies (CNES, JAXA, DLR) and aerospace industries (Airbus, Thales, Mitsubishi Heavy Industries)" | INSTITUTION | National space agencies and aerospace companies by country |
| 85 | src/app/chapters/space-technology/page.tsx | Key Insight (line 567-568) | "NASA's Jet Propulsion Laboratory...NASA's Goddard Space Flight Center" | INSTITUTION | NASA centers by location (CA and MD) |
| 86 | src/app/chapters/space-technology/page.tsx | Key Insight (line 569) | "Colorado, home to Lockheed Martin Space, United Launch Alliance, and Ball Aerospace" | INSTITUTION | Aerospace firms headquartered in Colorado |
| 87 | src/app/chapters/space-technology/page.tsx | Filing chart caption (line 887) | "coinciding with the commercial space investment boom (SpaceX, Blue Origin, satellite mega-constellations)" | INSTITUTION | SpaceX and Blue Origin as commercial space investors |
| 88 | src/app/chapters/ai-patents/page.tsx | Key Findings (line 281) | "AI patent filings have exhibited substantial growth since 2012, coinciding with advances in deep learning" | TECHNOLOGY_CONTEXT | Deep learning advances circa 2012 as driver |
| 89 | src/app/chapters/ai-patents/page.tsx | Exec Summary (line 290) | "a single methodological breakthrough -- the deep learning revolution of the early 2010s" | TECHNOLOGY_CONTEXT | Deep learning revolution dated to early 2010s |
| 90 | src/app/chapters/ai-patents/page.tsx | Key Insight (line 810-812) | "The growth in team sizes and corporate dominance in AI patenting predates the DABUS debate regarding AI-as-inventor" | CASE | Reference to DABUS case (AI-as-inventor debate) |
| 91 | src/app/chapters/autonomous-vehicles/page.tsx | Exec Summary (line 275) | "What began with Google's self-driving project in 2009...The 2016 Tesla Autopilot crash and subsequent safety debates" | TECHNOLOGY_CONTEXT | Google self-driving project start 2009; Tesla Autopilot crash 2016 |
| 92 | src/app/chapters/autonomous-vehicles/page.tsx | Exec Summary (line 275) | "The debate between lidar-based and camera-based perception systems -- exemplified by Waymo and Tesla respectively" | TECHNOLOGY_CONTEXT | Waymo = lidar approach; Tesla = camera approach |
| 93 | src/app/chapters/autonomous-vehicles/page.tsx | Caption (line 309) | "coinciding with Google's self-driving project gaining visibility" | TECHNOLOGY_CONTEXT | Google self-driving project visibility circa 2012 |
| 94 | src/app/chapters/quantum-computing/page.tsx | Exec Summary (line 276) | "Richard Feynman's 1982 proposal for quantum simulation marking an intellectual starting point" | HISTORY | Feynman's 1982 quantum simulation proposal |
| 95 | src/app/chapters/quantum-computing/page.tsx | Exec Summary (line 276) | "Google's 2019 quantum supremacy demonstration accelerated both corporate investment and patenting activity" | TECHNOLOGY_CONTEXT | Google quantum supremacy in 2019 |
| 96 | src/app/chapters/quantum-computing/page.tsx | Key Findings (line 268) | "IBM, Google, D-Wave, and Microsoft dominate quantum computing patenting, investing heavily in superconducting qubits, trapped ions, and software toolchains." | INSTITUTION | Leading quantum computing firms and their technology approaches |
| 97 | src/app/chapters/semiconductors/page.tsx | Key Findings (line 269) | "The CHIPS and Science Act of 2022 represents the most significant US policy intervention in semiconductor manufacturing in decades" | LAW | CHIPS and Science Act, 2022 |
| 98 | src/app/chapters/semiconductors/page.tsx | Exec Summary (line 275) | "The passage of the CHIPS Act in 2022 signals a renewed US policy commitment to domestic semiconductor manufacturing" | LAW | CHIPS Act 2022, policy commitment |
| 99 | src/app/chapters/cybersecurity/page.tsx | Key Findings (line 267) | "Cybersecurity patent filings have grown...with notable acceleration in filings observed following major security incidents such as the Snowden disclosures (2013), the WannaCry ransomware campaign (2017), and the SolarWinds supply-chain compromise (2020)." | TECHNOLOGY_CONTEXT | Snowden disclosures 2013; WannaCry 2017; SolarWinds 2020 |
| 100 | src/app/chapters/cybersecurity/page.tsx | Key Findings (line 268) | "Network security constitutes the largest cybersecurity subfield...having surpassed cryptography around 2003, coinciding with the expansion of cloud computing" | TECHNOLOGY_CONTEXT | Network security surpassing cryptography ~2003 |
| 101 | src/app/chapters/cybersecurity/page.tsx | Narrative (line 299-301) | "the Snowden disclosures (2013), WannaCry ransomware campaign (2017), and SolarWinds attack (2020)...regulatory responses such as GDPR" | TECHNOLOGY_CONTEXT | Major cybersecurity incidents and dates; GDPR reference |
| 102 | src/app/chapters/cybersecurity/page.tsx | Key Insight (line 333-335) | "WannaCry ransomware campaign of 2017 and the European Union's General Data Protection Regulation...the SolarWinds supply-chain attack of 2020" | TECHNOLOGY_CONTEXT | WannaCry 2017; EU GDPR; SolarWinds 2020 |
| 103 | src/app/chapters/cybersecurity/page.tsx | CR4 caption (line 827) | "IBM's pioneering role in cryptographic research (including DES)" | INSTITUTION | IBM's role in DES cryptographic standard |
| 104 | src/app/chapters/digital-health/page.tsx | Key Findings (line 277) | "Digital health patent filings have grown substantially since 2009, with notable growth following the 2009 HITECH Act's mandate for electronic health record adoption and the 2020 COVID-19 pandemic, which coincided with rapid expansion of telemedicine adoption." | LAW | HITECH Act 2009 mandating EHR adoption |
| 105 | src/app/chapters/digital-health/page.tsx | Key Insight (line 338) | "followed the 2009 HITECH Act, which allocated billions in incentive payments for..." | LAW | HITECH Act allocated billions for EHR incentives |
| 106 | src/app/chapters/green-innovation/page.tsx | Key Findings (line 300) | "Batteries and storage, transportation and electric vehicles, and renewable energy have exhibited continued growth in patent filings since the 2015 Paris Agreement" | POLICY | 2015 Paris Agreement as policy context |
| 107 | src/app/chapters/green-innovation/page.tsx | Key Insight (line 400-401) | "declining battery costs, automaker electrification strategies, and supportive policies such as the Inflation Reduction Act" | LAW | Inflation Reduction Act as supportive policy |
| 108 | src/app/chapters/green-innovation/page.tsx | Velocity caption (line 836) | "the acceleration of climate technology patenting coinciding with government subsidies, ESG mandates, and the Paris Agreement" | POLICY | Paris Agreement as driver of climate tech patenting |
| 109 | src/app/chapters/agricultural-technology/page.tsx | Caption (line 313) | "notable accelerations following the introduction of genetically modified crops in 1996 and the precision agriculture expansion accelerating markedly from 2018" | TECHNOLOGY_CONTEXT | GM crop adoption date 1996; precision ag boom ~2018 |
| 110 | src/app/chapters/agricultural-technology/page.tsx | Key Insight (line 413) | "since the adoption of genetically modified crops in 1996" | TECHNOLOGY_CONTEXT | GM crop adoption 1996 |
| 111 | src/app/about/page.tsx | FAQ (line 69) | "The America Invents Act (AIA) of 2011 was the most consequential US patent reform since the 1952 Patent Act. It shifted the US from a first-to-invent to a first-to-file system, created new post-grant review proceedings, and expanded prior art definitions." | LAW | AIA 2011; Patent Act of 1952; first-to-file; post-grant review |
| 112 | src/app/about/page.tsx | FAQ (line 53) | "The acceleration began after breakthroughs in deep neural networks in 2012" | TECHNOLOGY_CONTEXT | Deep neural network breakthroughs in 2012 |
| 113 | src/app/about/page.tsx | FAQ (line 73) | "The most prolific inventor, Shunpei Yamazaki, holds 6,709 US patents." | INSTITUTION | Shunpei Yamazaki as most prolific inventor; 6,709 patents |
| 114 | src/app/faq/page.tsx | FAQ (line 52) | "The acceleration began after breakthroughs in deep neural networks in 2012 and intensified further with the emergence of generative AI technologies after 2020." | TECHNOLOGY_CONTEXT | Deep neural net breakthroughs 2012; generative AI after 2020 |
| 115 | src/app/faq/page.tsx | FAQ (line 68) | "The most prolific inventor, Shunpei Yamazaki, holds 6,709 US patents spanning 1980-2025." | INSTITUTION | Yamazaki patent count and career span |
| 116 | src/app/methodology/page.tsx | Field Classification (line 254-257) | "The Cooperative Patent Classification (CPC) system is a hierarchical classification jointly managed by the USPTO and the European Patent Office (EPO)...The CPC was formally introduced in 2013; historical patents were retrospectively reclassified." | METHODOLOGY | CPC managed jointly by USPTO and EPO; introduced 2013; retroactive reclassification |
| 117 | src/app/methodology/page.tsx | WIPO (line 288-290) | "The World Intellectual Property Organization (WIPO) groups patents into 35 technology fields across 5 sectors: Electrical Engineering, Instruments, Chemistry, Mechanical Engineering, and Other Fields." | METHODOLOGY | WIPO classification structure: 35 fields, 5 sectors |
| 118 | src/app/methodology/page.tsx | Filing route (line 366) | "PCT (filed via the Patent Cooperation Treaty and entering the US national phase)" | METHODOLOGY | PCT treaty filing mechanism |
| 119 | src/app/chapters/geo-international/page.tsx | PCT section (line 515) | "The Patent Cooperation Treaty (PCT) route provides a standardized international filing pathway." | METHODOLOGY | PCT as standardized international filing pathway |
| 120 | src/app/chapters/system-patent-law/page.tsx | Data Note (line 816-821) | "Academic research summaries draw from published studies in leading economics and management journals including the American Economic Review, Quarterly Journal of Economics, Journal of Political Economy, Review of Economic Studies, Management Science, Strategic Management Journal, and Academy of Management Journal." | CITATION | List of journal sources used for research summaries |
| 121 | src/app/chapters/biotechnology/page.tsx | Geographic (line 563-564) | "the United States...benefits from the world's largest biomedical research funding apparatus through the National Institutes of Health" | INSTITUTION | NIH as world's largest biomedical research funder |
| 122 | src/app/chapters/biotechnology/page.tsx | Key Insight (line 598-601) | "Iowa ranks sixth nationally, anchored by Pioneer Hi-Bred's agricultural biotechnology headquarters" | INSTITUTION | Pioneer Hi-Bred headquarters location in Iowa |
| 123 | src/app/chapters/blockchain/page.tsx | Key Insight (line 461) | "Intel's strong second-place position underscores the hardware and cryptographic infrastructure dimensions" | INSTITUTION | Intel's blockchain focus on hardware/cryptographic infrastructure |
| 124 | src/app/chapters/blockchain/page.tsx | Key Insight (line 463-464) | "Alibaba-affiliated entities mirror the Chinese technology sector's aggressive blockchain strategy, particularly in supply chain and payment applications" | INSTITUTION | Alibaba's blockchain strategy focus |
| 125 | src/app/chapters/blockchain/page.tsx | Key Insight (line 565-566) | "China has pursued enterprise blockchain applications...even as it restricted cryptocurrency trading" | POLICY | China's restriction of cryptocurrency trading |
| 126 | src/app/chapters/blockchain/page.tsx | Key Insight (line 693) | "IBM's blockchain portfolio emphasizes distributed ledger infrastructure, consistent with its investment in the Hyperledger framework and enterprise blockchain consulting." | INSTITUTION | IBM's Hyperledger investment and consulting |
| 127 | src/app/chapters/space-technology/page.tsx | Key Insight (line 477) | "The consolidation of defense contractors (such as the formation of Northrop Grumman through mergers)" | INSTITUTION | Northrop Grumman formed through defense contractor mergers |
| 128 | src/app/chapters/3d-printing/page.tsx | Key Insight (line 404-405) | "the core methods of fused deposition modeling, stereolithography, selective laser sintering, and powder bed fusion" | DEFINITION | Lists core AM process technologies |
| 129 | src/app/chapters/3d-printing/page.tsx | Key Insight (line 548-549) | "Germany's strong position reflects its engineering and precision manufacturing tradition, with firms like EOS, SLM Solutions, and Siemens" | INSTITUTION | German AM firms: EOS, SLM Solutions, Siemens |
| 130 | src/app/chapters/3d-printing/page.tsx | Key Insight (line 814) | "The 2005 peak reflects Micron Technology's dominance during its semiconductor-adjacent AM activity." | INSTITUTION | Micron Technology's AM patenting activity |
| 131 | src/app/chapters/ai-patents/page.tsx | Narrative (line 691-692) | "general-purpose technologies (GPTs) is their diffusion into multiple sectors of the economy" | DEFINITION | Definition of general-purpose technology |
| 132 | src/app/chapters/system-patent-law/page.tsx | Key Findings (line 462) | "the most significant patent reform since 1952" | HISTORY | AIA's historical significance relative to 1952 Patent Act |
| 133 | src/lib/referenceEvents.ts | PATENT_EVENTS (line 12) | "Dot-com bust" at year 2001 | HISTORY | Dot-com bust dated to 2001 |
| 134 | src/lib/referenceEvents.ts | PATENT_EVENTS (line 16) | "Financial crisis" at year 2008 | HISTORY | Financial crisis dated to 2008 |
| 135 | src/lib/referenceEvents.ts | GREEN_EVENTS (line 24) | "Kyoto Protocol" at year 1997 | POLICY | Kyoto Protocol dated to 1997 |
| 136 | src/lib/referenceEvents.ts | GREEN_EVENTS (line 25) | "Paris Agreement" at year 2015 | POLICY | Paris Agreement dated to 2015 |
| 137 | src/lib/referenceEvents.ts | GREEN_EVENTS (line 26) | "Inflation Reduction Act" at year 2022 | LAW | Inflation Reduction Act dated to 2022 |
| 138 | src/lib/referenceEvents.ts | SEMI_EVENTS (line 32) | "CHIPS Act" at year 2022 | LAW | CHIPS Act dated to 2022 |
| 139 | src/lib/referenceEvents.ts | QUANTUM_EVENTS (line 36) | "Quantum supremacy" at year 2019 | TECHNOLOGY_CONTEXT | Quantum supremacy demonstration dated to 2019 |
| 140 | src/lib/referenceEvents.ts | QUANTUM_EVENTS (line 37) | "Quantum error correction" at year 2023 | TECHNOLOGY_CONTEXT | Quantum error correction milestone dated to 2023 |
| 141 | src/lib/referenceEvents.ts | CYBER_EVENTS (line 41) | "Snowden leaks" at year 2013 | HISTORY | Snowden leaks dated to 2013 |
| 142 | src/lib/referenceEvents.ts | CYBER_EVENTS (line 42) | "WannaCry / GDPR" at year 2017 | HISTORY | WannaCry and GDPR dated to 2017 |
| 143 | src/lib/referenceEvents.ts | CYBER_EVENTS (line 43) | "SolarWinds hack" at year 2020 | HISTORY | SolarWinds hack dated to 2020 |
| 144 | src/lib/referenceEvents.ts | BIOTECH_EVENTS (line 48) | "Human Genome complete" at year 2003 | TECHNOLOGY_CONTEXT | Human Genome Project completion dated to 2003 |
| 145 | src/lib/referenceEvents.ts | BIOTECH_EVENTS (line 49) | "CRISPR published" at year 2012 | TECHNOLOGY_CONTEXT | CRISPR publication dated to 2012 |
| 146 | src/lib/referenceEvents.ts | BIOTECH_EVENTS (line 50) | "mRNA vaccines" at year 2020 | TECHNOLOGY_CONTEXT | mRNA vaccines dated to 2020 |
| 147 | src/lib/referenceEvents.ts | DIGIHEALTH_EVENTS (line 54) | "HITECH Act" at year 2009 | LAW | HITECH Act dated to 2009 |
| 148 | src/lib/referenceEvents.ts | DIGIHEALTH_EVENTS (line 55) | "COVID-19 / telemedicine" at year 2020 | HISTORY | COVID-19 and telemedicine expansion dated to 2020 |
| 149 | src/lib/referenceEvents.ts | AGTECH_EVENTS (line 59) | "GM crops adopted" at year 1996 | TECHNOLOGY_CONTEXT | GM crop adoption dated to 1996 |
| 150 | src/lib/referenceEvents.ts | AGTECH_EVENTS (line 60) | "Precision ag boom" at year 2012 | TECHNOLOGY_CONTEXT | Precision agriculture boom dated to 2012 |
| 151 | src/lib/referenceEvents.ts | AV_EVENTS (line 64) | "Google self-driving start" at year 2009 | TECHNOLOGY_CONTEXT | Google self-driving project start dated to 2009 |
| 152 | src/lib/referenceEvents.ts | AV_EVENTS (line 65) | "Tesla Autopilot crash" at year 2016 | TECHNOLOGY_CONTEXT | Tesla Autopilot crash dated to 2016 |
| 153 | src/lib/referenceEvents.ts | AV_EVENTS (line 66) | "Waymo public launch" at year 2020 | TECHNOLOGY_CONTEXT | Waymo public launch dated to 2020 |
| 154 | src/lib/referenceEvents.ts | SPACE_EVENTS (line 70) | "SpaceX founded" at year 2002 | INSTITUTION | SpaceX founding dated to 2002 |
| 155 | src/lib/referenceEvents.ts | SPACE_EVENTS (line 71) | "Falcon 9 landing" at year 2015 | TECHNOLOGY_CONTEXT | Falcon 9 first landing dated to 2015 |
| 156 | src/lib/referenceEvents.ts | SPACE_EVENTS (line 72) | "Crew Dragon launch" at year 2020 | TECHNOLOGY_CONTEXT | Crew Dragon launch dated to 2020 |
| 157 | src/lib/referenceEvents.ts | PRINT3D_EVENTS (line 76) | "FDM patent expires" at year 2009 | TECHNOLOGY_CONTEXT | FDM patent expiration dated to 2009 |
| 158 | src/lib/referenceEvents.ts | PRINT3D_EVENTS (line 77) | "Desktop 3D printing boom" at year 2014 | TECHNOLOGY_CONTEXT | Desktop 3D printing boom dated to 2014 |
| 159 | src/lib/referenceEvents.ts | BLOCKCHAIN_EVENTS (line 81) | "Bitcoin whitepaper" at year 2009 | TECHNOLOGY_CONTEXT | Bitcoin whitepaper dated to 2009 |
| 160 | src/lib/referenceEvents.ts | BLOCKCHAIN_EVENTS (line 82) | "Ethereum launch" at year 2015 | TECHNOLOGY_CONTEXT | Ethereum launch dated to 2015 |
| 161 | src/lib/referenceEvents.ts | BLOCKCHAIN_EVENTS (line 83) | "Crypto / NFT peak" at year 2021 | TECHNOLOGY_CONTEXT | Crypto/NFT market peak dated to 2021 |
| 162 | src/app/chapters/system-patent-law/page.tsx | Impact section (line 527-528) | "State Street Bank v. Signature Financial Group (1998): Established the patentability of business methods, The subsequent acceleration in software patent filings is consistent with this ruling, observable as the acceleration of Section G (Physics) and H (Electricity) patents in the late 1990s" | CASE | State Street holding and its observed effects on patent filings |
| 163 | src/app/chapters/system-patent-law/page.tsx | Impact section (line 534-535) | "The shift to first-inventor-to-file changed priority rules for all patents filed after March 2013." | LAW | AIA first-to-file effective date March 2013 |
| 164 | src/app/chapters/biotechnology/page.tsx | Geographic (line 547) | "reflecting its extensive network of research universities, NIH-funded research, and pharmaceutical industry concentration" | INSTITUTION | US biotech ecosystem description: universities, NIH, pharma |
| 165 | src/app/chapters/biotechnology/page.tsx | Ethical (line 851-853) | "Gene editing technologies raise particularly acute ethical questions. The ability to modify human germline cells -- changes that would be inherited by future generations -- has prompted international calls for moratoriums" | POLICY | International germline editing moratorium calls |
| 166 | src/app/chapters/digital-health/page.tsx | Exec Summary (line 286) | "regulatory mandates and public health emergencies (COVID-19)...advances in sensor technology, wireless connectivity, and cloud computing" | TECHNOLOGY_CONTEXT | COVID-19 as driver of digital health; technology enablers |
| 167 | src/app/chapters/green-innovation/page.tsx | Narrative (line 317) | "Climate change constitutes one of the defining challenges of the 21st century" | HISTORY | Characterization of climate change as defining challenge |
| 168 | src/app/chapters/space-technology/page.tsx | Assignee section (line 783) | "private-sector investment now exceeds government funding for many categories of space technology development" | COMPARATIVE | External claim about private vs government space funding |
| 169 | src/app/chapters/quantum-computing/page.tsx | Key Findings (line 269) | "Error correction remains a central challenge, and patents in error correction...have expanded substantially as the field moves toward fault-tolerant quantum computation." | TECHNOLOGY_CONTEXT | Quantum error correction as central challenge; fault-tolerant goal |
| 170 | src/app/chapters/semiconductors/page.tsx | Key Findings (line 267) | "East Asian firms -- Samsung and TSMC -- have emerged as dominant patent holders alongside US-based incumbents such as IBM and Micron" | INSTITUTION | Samsung, TSMC, IBM, Micron as semiconductor patent leaders |
| 171 | src/app/chapters/autonomous-vehicles/page.tsx | Key Findings (line 268) | "The competitive landscape spans traditional automakers (Toyota, Honda, Ford, GM), technology firms (Google/Waymo), and other technology companies" | INSTITUTION | AV competitive landscape: automakers and tech firms |
| 172 | src/app/chapters/system-patent-law/page.tsx | Impact (line 516-519) | "Bayh-Dole Act (1980): Coincided with a substantial increase in university patenting, though scholars debate whether the Act catalyzed the trend or formalized an existing one." | HISTORY | Scholarly debate about Bayh-Dole's causal role |
| 173 | src/app/chapters/system-patent-law/page.tsx | Impact (line 521-523) | "Court of Appeals for the Federal Circuit (1982): Unified and strengthened patent rights, a change widely cited as a factor in the upward trend in patent grants through the 1990s and 2000s" | HISTORY | Federal Circuit's role in patent growth trend |
| 174 | src/app/methodology/page.tsx | Quality metrics (line 389) | "The 5-year window is standard in the patent analytics literature" | METHODOLOGY | 5-year citation window as established standard |
| 175 | src/app/chapters/system-patent-law/page.tsx | Insight (line 499-503) | "an era of expansion and strengthening (1982-2000) shaped by the Court of Appeals for the Federal Circuit...followed by an era of recalibration (2006-present) as the Supreme Court narrowed patent scope" | HISTORY | Two-era characterization of patent law trajectory with date ranges |
